dc.contributor.author | Bex, Axel | |
dc.contributor.author | Mulders, Peter | |
dc.contributor.author | Jewett, Michael | |
dc.contributor.author | Wagstaff, John | |
dc.contributor.author | Van Thienen, Johannes V. | |
dc.contributor.author | Blank, Christian U. | |
dc.contributor.author | Van Velthoven, Roland | |
dc.contributor.author | Laguna, Maria del Pilar | |
dc.contributor.author | Wood, Lori | |
dc.contributor.author | Van Melick, Harm H. E. | |
dc.contributor.author | Aarts, Maureen J. | |
dc.contributor.author | Lattouf, Jean-Baptiste | |
dc.contributor.author | Powles, Thomas | |
dc.contributor.author | De Jong, Igle Jan | |
dc.contributor.author | Rottey, Sylvie | |
dc.contributor.author | Tombal, Bertrand | |
dc.contributor.author | Marreaud, Sandrine | |
dc.contributor.author | Collette, Sandra | |
dc.contributor.author | Collette, Laurence | |
dc.contributor.author | Haanen, John | |
dc.date.accessioned | 2020-03-25T07:22:33Z | |
dc.date.available | 2020-03-25T07:22:33Z | |
dc.date.issued | 2019 | en_US |
dc.identifier.citation | Bex, A., Mulders, P., Jewett, M., Wagstaff, J., Van Thienen, J., Blank, C. ... Haanen, J. (2019). Comparison of immediate vs deferred cytoreductive nephrectomy in patients with synchronous metastatic renal cell carcinoma receiving sunitinib: the SURTIME randomized clinical trial (vol 5, pg 164, 2018). Journal of Jama Oncology, 5(2), 271-271. https://dx.doi.org/10.1001/jamaoncol.2019.0117 | en_US |
dc.identifier.issn | 2374-2437 | |
dc.identifier.issn | 2374-2445 | |
dc.identifier.uri | http://doi.org/10.1001/jamaoncol.2019.0117 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12511/5091 | |
dc.description.abstract | ... | en_US |
dc.language.iso | eng | en_US |
dc.publisher | American Medical Association | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Clinical | en_US |
dc.subject | Metastatic Renal Cell Carcinoma | en_US |
dc.subject | Cytoreductive Nephrectomy (CN) | en_US |
dc.title | Comparison of immediate vs deferred cytoreductive nephrectomy in patients with synchronous metastatic renal cell carcinoma receiving sunitinib: the SURTIME randomized clinical trial (vol 5, pg 164, 2018) | en_US |
dc.type | other | en_US |
dc.relation.ispartof | Jama Oncology | en_US |
dc.department | İstanbul Medipol Üniversitesi, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Üroloji Ana Bilim Dalı | en_US |
dc.identifier.volume | 5 | en_US |
dc.identifier.issue | 2 | en_US |
dc.identifier.startpage | 271 | en_US |
dc.identifier.endpage | 271 | en_US |
dc.relation.publicationcategory | Diğer | en_US |
dc.identifier.wosquality | Q1 | en_US |